2025 annual financial data
C4 Therapeutics, Inc. 2025 Operating margin
C4 Therapeutics, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was -290.68%.
Operating income was -104,489,000 USD and net income was -104,994,000 USD.
Operating cash flow was -98,694,000 USD.
Get free C4 Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,947,000 USD
- Operating income
- -104,489,000 USD
- Net income
- -104,994,000 USD
- Operating cash flow
- -98,694,000 USD